These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8556394)

  • 61. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T; Kurth R; Norley S
    J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
    [TBL] [Abstract][Full Text] [Related]  

  • 62. V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.
    Michael NL; Davis KE; Loomis-Price LD; VanCott TC; Burke DS; Redfield RR; Birx DL
    AIDS; 1996 Feb; 10(2):121-9. PubMed ID: 8838699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
    Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
    Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.
    Safrit JT; Lee AY; Andrews CA; Koup RA
    J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
    Ebenbichler C; Westervelt P; Carrillo A; Henkel T; Johnson D; Ratner L
    AIDS; 1993 May; 7(5):639-46. PubMed ID: 7686374
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels.
    Warren RQ; Wolf H; Zajac RA; Boswell RN; Kanda P; Kennedy RC
    J Clin Immunol; 1991 Jan; 11(1):13-21. PubMed ID: 1708780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
    Zolla-Pazner S; Cohen SS; Krachmarov C; Wang S; Pinter A; Lu S
    Virology; 2008 Mar; 372(2):233-46. PubMed ID: 18061228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
    Shirai M; Chen M; Arichi T; Masaki T; Nishioka M; Newman M; Nakazawa T; Feinstone SM; Berzofsky JA
    J Infect Dis; 1996 Jan; 173(1):24-31. PubMed ID: 8537666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual.
    Lieberman J; Fabry JA; Fong DM; Parkerson GR
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):383-92. PubMed ID: 9075479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B; Steimer KS; Walker CM
    Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
    Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
    J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
    Bckström M; Holmgren J; Schödel F; Lebens M
    Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.
    Gorny MK; Mascola JR; Israel ZR; VanCott TC; Williams C; Balfe P; Hioe C; Brodine S; Burda S; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):213-21. PubMed ID: 9491911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH; Messer KG; Nara PL; Blattner WA; Colclough G; Reitz M
    J Clin Invest; 1994 Jun; 93(6):2505-13. PubMed ID: 7515393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The HIV-1 gp120/V3 modifies the response of uninfected CD4 T cells to antigen presentation: mapping of the specific transcriptional signature.
    Morou AK; Porichis F; Krambovitis E; Sourvinos G; Spandidos DA; Zafiropoulos A
    J Transl Med; 2011 Sep; 9():160. PubMed ID: 21943198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.